TrialAntimicrobial agents and chemotherapy2008

Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity.

Helen Cooksley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.